Long non‑coding RNA LINC01006 exhibits oncogenic properties in cervical cancer by functioning as a molecular sponge for microRNA‑28‑5p and increasing PAK2 expression

Tian,Libin; Han,Feng; Yang,Jing; Ming,Xiaoqiong; Chen,Lili

doi:10.3892/ijmm.2021.4879

Long non‑coding RNA LINC01006 exhibits oncogenic properties in cervical cancer by functioning as a molecular sponge for microRNA‑28‑5p and increasing PAK2 expression

Authors:
- Libin Tian
- Feng Han
- Jing Yang
- Xiaoqiong Ming
- Lili Chen
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China, Department of Respiratory Medicine, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430015, P.R. China, Department of Obstetrics and Gynecology, China Resources WISCO General Hospital, Wuhan, Hubei 430080, P.R. China
Published online on: February 9, 2021 https://doi.org/10.3892/ijmm.2021.4879
Article Number: 46
Copyright: © Tian et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

As previously reported, long intergenic non‑protein‑coding RNA 1006 (LINC01006) plays crucial roles in prostate, pancreatic and gastric cancers. However, whether it plays important roles in cervical cancer remains unclear. The present study thus aimed to determine the precise role of LINC01006 in cervical cancer and elucidate its regulatory mechanisms. The expression of LINC01006 in cervical cancer was examined by reverse transcription‑quantitative polymerase chain reaction. Cell proliferation assay, flow cytometric analysis, Transwell migration and invasion assays, and tumor xenograft model experiments were performed to elucidate the roles of LINC01006 in cervical cancer. Bioinformatics analysis, luciferase reporter assay, RNA immunoprecipitation and rescue experiments were performed for mechanistic analyses. The expression of LINC01006 was found to be upregulated in cervical cancer and to be associated with a poor prognosis. The absence of LINC01006 inhibited the proliferation, migration and invasion of cervical cancer cells, whereas it promoted cell apoptosis in vitro. The downregulation of LINC01006 impeded tumor growth in vivo. LINC01006 was verified as an endogenous ‘sponge’ that competed for microRNA‑28‑5p (miR‑28‑5p), which resulted in the upregulation of the miR‑28‑5p target P21‑activated kinase 2 (PAK2). Rescue experiments revealed that the suppression of miR‑28‑5p expression or the overexpression of PAK2 abrogated the effects of LINC01006 downregulation on malignant cellular functions in cervical cancer. On the whole, the present study demonstrates that LINC01006 exhibits tumor‑promoting functions in cervical cancer via the regulation of the miR‑28‑5p/PAK2 axis. These findings may provide the basis for the identification of LINC01006‑targeted clinical therapy.

View Figures

View References

1	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
2	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
3	Fang J, Zhang H and Jin S: Epigenetics and cervical cancer: From pathogenesis to therapy. Tumour Biol. 35:5083–5093. 2014. View Article : Google Scholar : PubMed/NCBI
4	Tsikouras P, Zervoudis S, Manav B, Tomara E, Iatrakis G, Romanidis C, Bothou A and Galazios G: Cervical cancer: Screening, diagnosis and staging. J BUON. 21:320–325. 2016.PubMed/NCBI
5	Lin M, Ye M, Zhou J, Wang ZP and Zhu X: Recent advances on the molecular mechanism of cervical carcinogenesis based on systems biology technologies. Comput Struct Biotechnol J. 17:241–250. 2019. View Article : Google Scholar : PubMed/NCBI
6	Sarfi M, Abbastabar M and Khalili E: Long noncoding RNAs biomarker-based cancer assessment. J Cell Physiol. 234:16971–16986. 2019. View Article : Google Scholar : PubMed/NCBI
7	Ransohoff JD, Wei Y and Khavari PA: The functions and unique features of long intergenic non-coding RNA. Nat Rev Mol Cell Biol. 19:143–157. 2018. View Article : Google Scholar :
8	Shi X, Sun M, Wu Y, Yao Y, Liu H, Wu G, Yuan D and Song Y: Post-transcriptional regulation of long noncoding RNAs in cancer. Tumour Biol. 36:503–513. 2015. View Article : Google Scholar : PubMed/NCBI
9	Ponting CP, Oliver PL and Reik W: Evolution and functions of long noncoding RNAs. Cell. 136:629–641. 2009. View Article : Google Scholar : PubMed/NCBI
10	Ramakrishnaiah Y, Kuhlmann L and Tyagi S: Towards a comprehensive pipeline to identify and functionally annotate long noncoding RNA (lncRNA). Comput Biol Med. 127:1040282020. View Article : Google Scholar
11	Luo F, Wen Y, Zhou H and Li Z: Roles of long non-coding RNAs in cervical cancer. Life Sci. 256:1179812020. View Article : Google Scholar
12	He J, Huang B, Zhang K, Liu M and Xu T: Long non-coding RNA in cervical cancer: From biology to therapeutic opportunity. Biomed Pharmacother. 127:1102092020. View Article : Google Scholar
13	Galvão M and Coimbra EC: Long noncoding RNAs (lncRNAs) in cervical carcinogenesis: New molecular targets, current prospects. Crit Rev Oncol Hematol. 156:1031112020. View Article : Google Scholar : PubMed/NCBI
14	Acunzo M, Romano G, Wernicke D and Croce CM: MicroRNA and cancer-a brief overview. Adv Biol Regul. 57:1–9. 2015. View Article : Google Scholar
15	Adams BD, Kasinski AL and Slack FJ: Aberrant regulation and function of microRNAs in cancer. Curr Biol. 24:R762–R776. 2014. View Article : Google Scholar : PubMed/NCBI
16	Miao J, Regenstein JM, Xu D, Zhou D, Li H, Zhang H, Li C, Qiu J and Chen X: The roles of microRNA in human cervical cancer. Arch Biochem Biophys. 690:1084802020. View Article : Google Scholar : PubMed/NCBI
17	Shen S, Zhang S, Liu P, Wang J and Du H: Potential role of microRNAs in the treatment and diagnosis of cervical cancer. Cancer Genet. 248-249:25–30. 2020. View Article : Google Scholar : PubMed/NCBI
18	Tornesello ML, Faraonio R, Buonaguro L, Annunziata C, Starita N, Cerasuolo A, Pezzuto F, Tornesello AL and Buonaguro FM: The role of microRNAs, long non-coding RNAs, and circular RNAs in cervical cancer. Front Oncol. 10:1502020. View Article : Google Scholar : PubMed/NCBI
19	Ye Y, Shen A and Liu A: Long non-coding RNA H19 and cancer: A competing endogenous RNA. Bull Cancer. 106:1152–1159. 2019. View Article : Google Scholar : PubMed/NCBI
20	Ma E, Wang Q, Li J, Zhang X, Guo Z and Yang X: LINC01006 facilitates cell proliferation, migration and invasion in prostate cancer through targeting miR-34a-5p to up-regulate DAAM1. Cancer Cell Int. 20:5152020. View Article : Google Scholar : PubMed/NCBI
21	Zhang L, Wang Y, Zhang L, You G, Li C, Meng B, Zhou M and Zhang M: LINC01006 promotes cell proliferation and metastasis in pancreatic cancer via miR-2682-5p/HOXB8 axis. Cancer Cell Int. 19:3202019. View Article : Google Scholar : PubMed/NCBI
22	Zhu X, Chen F, Shao Y, Xu D and Guo J: Long intergenic non-protein coding RNA 1006 used as a potential novel biomarker of gastric cancer. Cancer Biomark. 21:73–80. 2017. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
24	Duan DM, Zhang L and Hua F: LncRNA UCA1 inhibits proliferation and promotes apoptosis of cervical cancer cells by regulating beta-catenin/TCF-4. Eur Rev Med Pharmacol Sci. 24:5963–5969. 2020.
25	Yan A, Chen G and Nie J: DGUOK-AS1 promotes the proliferation cervical cancer through regulating miR-653-5p/EMSY. Cancer Biol Ther. 1–9. 2020. View Article : Google Scholar : PubMed/NCBI
26	Lin L, Xin B, Jiang T, Wang XL, Yang H and Shi TM: Long non-coding RNA LINC00460 promotes proliferation and inhibits apoptosis of cervical cancer cells by targeting microRNA-503-5p. Mol Cell Biochem. 475:1–13. 2020. View Article : Google Scholar : PubMed/NCBI
27	Xu J, Bai J, Zhang X, Lv Y, Gong Y, Liu L, Zhao H, Yu F, Ping Y, Zhang G, et al: A comprehensive overview of lncRNA annotation resources. Brief Bioinform. 18:236–249. 2017.
28	Niu ZS, Wang WH, Dong XN and Tian LM: Role of long noncoding RNA-mediated competing endogenous RNA regulatory network in hepatocellular carcinoma. World J Gastroenterol. 26:4240–4260. 2020. View Article : Google Scholar : PubMed/NCBI
29	Raziq K, Cai M, Dong K, Wang P, Afrifa J and Fu S: Competitive endogenous network of lncRNA, miRNA, and mRNA in the chemoresistance of gastrointestinal tract adenocarcinomas. Biomed Pharmacother. 130:1105702020. View Article : Google Scholar : PubMed/NCBI
30	Zhang XZ, Liu H and Chen SR: Mechanisms of long non-coding RNAs in cancers and their dynamic regulations. Cancers (Basel). 12:12452020. View Article : Google Scholar
31	Du H and Chen Y: Competing endogenous RNA networks in cervical cancer: Function, mechanism and perspective. J Drug Target. 27:709–723. 2019. View Article : Google Scholar
32	Zhang K, Shi ZM, Chang YN, Hu ZM, Qi HX and Hong W: The ways of action of long non-coding RNAs in cytoplasm and nucleus. Gene. 547:1–9. 2014. View Article : Google Scholar : PubMed/NCBI
33	Rashid F, Shah A and Shan G: Long non-coding RNAs in the cytoplasm. Genomics Proteomics Bioinformatics. 14:73–80. 2016. View Article : Google Scholar : PubMed/NCBI
34	Ma L, Zhang Y and Hu F: miR285p inhibits the migration of breast cancer by regulating WSB2. Int J Mol Med. 46:1562–1570. 2020.PubMed/NCBI
35	Zhang L, Wang X, Liu X, Lv M, Shen E, Zhu G and Sun Z: miR-28-5p targets MTSS1 to regulate cell proliferation and apoptosis in esophageal cancer. Acta Biochim Biophys Sin (Shanghai). 52:842–852. 2020. View Article : Google Scholar
36	Fazio S, Berti G, Russo F, Evangelista M, D'Aurizio R, Mercatanti A, Pellegrini M and Rizzo M: The miR-28-5p targetome discovery identified SREBF2 as one of the mediators of the miR-28-5p tumor suppressor activity in prostate cancer cells. Cells. 9:3542020. View Article : Google Scholar :
37	Nuche-Berenguer B, Ramos-Alvarez I and Jensen RT: The p21-activated kinase, PAK2, is important in the activation of numerous pancreatic acinar cell signaling cascades and in the onset of early pancreatitis events. Biochim Biophys Acta. 1862:1122–1136. 2016. View Article : Google Scholar : PubMed/NCBI
38	Knaus UG, Wang Y, Reilly AM, Warnock D and Jackson JH: Structural requirements for PAK activation by Rac GTPases. J Biol Chem. 273:21512–21518. 1998. View Article : Google Scholar : PubMed/NCBI
39	Liu H, Shin SH, Chen H, Liu T, Li Z, Hu Y, Liu F, Zhang C, Kim DJ, Liu K and Dong Z: CDK12 and PAK2 as novel therapeutic targets for human gastric cancer. Theranostics. 10:6201–6215. 2020. View Article : Google Scholar : PubMed/NCBI
40	Lee JS, Mo Y, Gan H, Burgess RJ, Baker DJ, van Deursen JM and Zhang Z: Pak2 kinase promotes cellular senescence and organismal aging. Proc Natl Acad Sci USA. 116:13311–13319. 2019. View Article : Google Scholar : PubMed/NCBI
41	Gupta A, Ajith A, Singh S, Panday RK, Samaiya A and Shukla S: PAK2-c-Myc-PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect. Cell Death Dis. 9:8252018. View Article : Google Scholar : PubMed/NCBI